Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines, gene sequencers, and supporting reagents in China. More Details
Mediocre balance sheet and overvalued.
Share Price & News
How has Jilin Zixin Pharmaceutical IndustrialLtd's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 002118 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 002118's weekly volatility (8%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: 002118 underperformed the CN Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: 002118 underperformed the CN Market which returned 28.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Jilin Zixin Pharmaceutical IndustrialLtd's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Jilin Zixin Pharmaceutical IndustrialLtd undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 002118 (CN¥3.11) is trading above our estimate of fair value (CN¥1.85)
Significantly Below Fair Value: 002118 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 002118 is unprofitable, so we can't compare its PE Ratio to the CN Pharmaceuticals industry average.
PE vs Market: 002118 is unprofitable, so we can't compare its PE Ratio to the CN market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 002118's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 002118 is good value based on its PB Ratio (1x) compared to the CN Pharmaceuticals industry average (2.7x).
How is Jilin Zixin Pharmaceutical IndustrialLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jilin Zixin Pharmaceutical IndustrialLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Jilin Zixin Pharmaceutical IndustrialLtd performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 002118 is currently unprofitable.
Growing Profit Margin: 002118 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 002118 is unprofitable, and losses have increased over the past 5 years at a rate of 40.7% per year.
Accelerating Growth: Unable to compare 002118's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002118 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (10.8%).
Return on Equity
High ROE: 002118 has a negative Return on Equity (-15.68%), as it is currently unprofitable.
How is Jilin Zixin Pharmaceutical IndustrialLtd's financial position?
Financial Position Analysis
Short Term Liabilities: 002118's short term assets (CN¥8.3B) exceed its short term liabilities (CN¥5.1B).
Long Term Liabilities: 002118's short term assets (CN¥8.3B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 002118's debt to equity ratio (128.9%) is considered high.
Reducing Debt: 002118's debt to equity ratio has reduced from 134.4% to 128.9% over the past 5 years.
Debt Coverage: 002118's debt is not well covered by operating cash flow (3.9%).
Interest Coverage: Insufficient data to determine if 002118's interest payments on its debt are well covered by EBIT.
What is Jilin Zixin Pharmaceutical IndustrialLtd current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 002118's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 002118's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 002118's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 002118's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 002118 is not paying a notable dividend for the CN market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 002118's dividend in 3 years as they are not forecast to pay a notable one for the CN market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Jilin Zixin Pharmaceutical IndustrialLtd has no CEO, or we have no data on them.
Experienced Board: 002118's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
- Ticker: 2118
- Exchange: SZSE
- Founded: 1998
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥3.983b
- Shares outstanding: 1.28b
- Website: https://www.jilinzixin.com.cn
Number of Employees
- Jilin Zixin Pharmaceutical Industrial Co.,Ltd.
- No. 137, Dongtoudao Street
- Nanguan District
- Jilin Province
Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines, gene sequencers, and supporting reagents in China. It provides ginseng products; prescription prod...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/11 09:06|
|End of Day Share Price||2021/04/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.